In 2023, adults younger than 65 with employer-sponsored insurance who received inpatient mental health treatment were most often treated for depressive disorders, while nearly three-fourths of substance use treatment stays were for alcohol-related disorders, according to a KFF  (https://www.healthsystemtracker.org/brief/cost-and-utilization-of-inpatient-mental-health-and-substance-use-treatment/)  analysis. 

The analysis reviewed 2023 Merative MarketScan Commercial Databases and included adults ages 18 to 65 who were enrolled in commercial insurance for at least six months. Only diagnostic categories accounting for at least 1% of inpatient treatment episodes were included. 

###